381 related articles for article (PubMed ID: 3033201)
1. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
Mittag TW; Tormay A; Podos SM
J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
[TBL] [Abstract][Full Text] [Related]
2. Calmodulin activated adenylyl cyclase in ciliary processes: additivity of calcium and cyclic adenosine monophosphate signals on intraocular pressure response of the rabbit eye.
Mittag TW; Tormay A; Taniguchi T; Ortega M
Invest Ophthalmol Vis Sci; 1993 May; 34(6):2041-8. PubMed ID: 8387978
[TBL] [Abstract][Full Text] [Related]
3. Phorbol ester: effect on intraocular pressure, adenylate cyclase, and protein kinase in the rabbit eye.
Mittag TW; Yoshimura N; Podos SM
Invest Ophthalmol Vis Sci; 1987 Dec; 28(12):2057-66. PubMed ID: 3679753
[TBL] [Abstract][Full Text] [Related]
4. Response and level of beta-adrenergic, vasoactive intestinal peptide, and PACAP receptors during the circadian cycle.
Hirota A; Kiuchi Y; Nii H; Gregory DS
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1708-18. PubMed ID: 9286259
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic cholinergic inhibition of adenylate cyclase in the rabbit iris-ciliary body and ciliary epithelium.
Jumblatt JE; North GT; Hackmiller RC
Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1103-8. PubMed ID: 2162335
[TBL] [Abstract][Full Text] [Related]
6. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
Birnbaum RS; Alfonzo M; Kowal J
Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of vasoactive intestinal peptide receptors by protein kinase C in fetal human non-pigmented ciliary epithelial cells.
Crook RB; Yabu JM
Exp Eye Res; 1994 Jul; 59(1):31-9. PubMed ID: 7835396
[TBL] [Abstract][Full Text] [Related]
9. Characterization of vasoactive intestinal peptide receptors in rabbit ciliary processes.
Horio B; Law NM; Rosenzweig SA
Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):192-9. PubMed ID: 7529752
[TBL] [Abstract][Full Text] [Related]
10. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalization.
Turner JT; Bollinger DW; Toews ML
J Pharmacol Exp Ther; 1988 Nov; 247(2):417-23. PubMed ID: 2846820
[TBL] [Abstract][Full Text] [Related]
12. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase.
Nilsson SF; De Neef P; Robberecht P; Christophe J
Exp Eye Res; 1994 Apr; 58(4):459-67. PubMed ID: 7925682
[TBL] [Abstract][Full Text] [Related]
13. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
Laburthe M; Couvineau A; Rouyer-Fessard C
Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561
[TBL] [Abstract][Full Text] [Related]
14. Interactions between forskolin, GS, and divalent cations on ciliary process adenylyl cyclase and intraocular pressure in the rabbit eye.
Mittag TW; Tormay A
Exp Eye Res; 1993 Jul; 57(1):13-9. PubMed ID: 8405168
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
[TBL] [Abstract][Full Text] [Related]
18. [Autoradiographic localization and characterization of the ocular binding sites of the VIP (vasoactive intestinal peptide) in albino rats and rabbits].
Denis P; Dussaillant M; Elena PP; Nordmann JP; Rostene W; Laroche L
Ophtalmologie; 1990; 4(1):30-2. PubMed ID: 2174530
[TBL] [Abstract][Full Text] [Related]
19. Forskolin lowers intraocular pressure by reducing aqueous inflow.
Caprioli J; Sears M; Bausher L; Gregory D; Mead A
Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):268-77. PubMed ID: 6538189
[TBL] [Abstract][Full Text] [Related]
20. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
Van Rampelbergh J; Gourlet P; De Neef P; Robberecht P; Waelbroeck M
Mol Pharmacol; 1996 Dec; 50(6):1596-604. PubMed ID: 8967982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
